Integration of the Microbiome, Metabolome and Transcriptome Reveals Escherichia coli F17 Susceptibility of Sheep.
Weihao ChenXiaoyang LvXiu-Kai CaoZehu YuanShanhe WangTesfaye GetachewJoram M MwacharoAynalem HaileKai QuanYutao LiWei SunPublished in: Animals : an open access journal from MDPI (2023)
Escherichia coli ( E. coli ) F17 is one of the most common pathogens causing diarrhea in farm livestock. In the previous study, we accessed the transcriptomic and microbiomic profile of E. coli F17-antagonism (AN) and -sensitive (SE) lambs; however, the biological mechanism underlying E. coli F17 infection has not been fully elucidated. Therefore, the present study first analyzed the metabolite data obtained with UHPLC-MS/MS. A total of 1957 metabolites were profiled in the present study, and 11 differential metabolites were identified between E. coli F17 AN and SE lambs (i.e., FAHFAs and propionylcarnitine). Functional enrichment analyses showed that most of the identified metabolites were related to the lipid metabolism. Then, we presented a machine-learning approach (Random Forest) to integrate the microbiome, metabolome and transcriptome data, which identified subsets of potential biomarkers for E. coli F17 infection (i.e., GlcADG 18:0-18:2, ethylmalonic acid and FBLIM1 ); furthermore, the PCCs were calculated and the interaction network was constructed to gain insight into the crosstalk between the genes, metabolites and bacteria in E. coli F17 AN/SE lambs. By combing classic statistical approaches and a machine-learning approach, our results revealed subsets of metabolites, genes and bacteria that could be potentially developed as candidate biomarkers for E. coli F17 infection in lambs.
Keyphrases
- escherichia coli
- ms ms
- machine learning
- genome wide
- single cell
- climate change
- electronic health record
- liquid chromatography tandem mass spectrometry
- pseudomonas aeruginosa
- dna methylation
- artificial intelligence
- cystic fibrosis
- staphylococcus aureus
- multidrug resistant
- irritable bowel syndrome
- ultra high performance liquid chromatography
- drug induced